Samuel Wickline
Directeur Technique/Scientifique/R&D chez ALTAMIRA THERAPEUTICS LTD.
Postes actifs de Samuel Wickline
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Directeur Technique/Scientifique/R&D | 01/06/2021 | - |
PixelEXX Systems, Inc.
 PixelEXX Systems, Inc. Miscellaneous Commercial ServicesCommercial Services PixelEXX Systems, Inc. manufactures semiconductor nanoarrays for molecular diagnostics and microscopy. The company was founded by Stuart Solin, Samuel A. Wickline, Kirk Wallace and Michael Hughes in 2007 and is headquartered in Chicago, IL. | Directeur/Membre du Conseil | 26/06/2014 | - |
| Fondateur | 03/11/2009 | - | |
| President | 01/01/2008 | - | |
| Washington University School of Medicine | Corporate Officer/Principal | - | - |
| University of South Florida | Corporate Officer/Principal | 01/11/2016 | - |
Historique de carrière de Samuel Wickline
Anciens postes connus de Samuel Wickline
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 01/01/1980 | 01/01/2016 |
| USF Health Morsani College of Medicine | Directeur/Membre du Conseil | - | - |
Trasir Therapeutics, Inc.
 Trasir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Altamira Therapeutics Ltd., Trasir Therapeutics, Inc. develops specialty pharmaceutical products. The company is based in Tampa, FL. The company was founded by Samuel A. Wickline. Trasir Therapeutics was acquired by Altamira Therapeutics Ltd. on June 03, 2021 for $4.32 million. | Fondateur | - | - |
Kereos, Inc.
 Kereos, Inc. Pharmaceuticals: MajorHealth Technology Kereos, Inc. develops and manufactures biotechnology products. The firm focuses on nanodroplet technology that allows delivery of a range of drug compounds to a target in the body for the treatment of diseases. The company was founded by Samuel A. Wickline and Gregory M. Lanza in 1999 and is headquartered in St. Louis, MO. | Directeur/Membre du Conseil | 01/01/1999 | - |
| Fondateur | 01/01/1999 | - |
Formation de Samuel Wickline
| University of Hawai'i at Hilo | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 9 |
| Bermudes | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Founder | 3 |
| Corporate Officer/Principal | 3 |
Sectorielle
| Consumer Services | 6 |
| Health Technology | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALTAMIRA THERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Kereos, Inc.
Kereos, Inc. Pharmaceuticals: MajorHealth Technology Kereos, Inc. develops and manufactures biotechnology products. The firm focuses on nanodroplet technology that allows delivery of a range of drug compounds to a target in the body for the treatment of diseases. The company was founded by Samuel A. Wickline and Gregory M. Lanza in 1999 and is headquartered in St. Louis, MO. | Health Technology |
PixelEXX Systems, Inc.
PixelEXX Systems, Inc. Miscellaneous Commercial ServicesCommercial Services PixelEXX Systems, Inc. manufactures semiconductor nanoarrays for molecular diagnostics and microscopy. The company was founded by Stuart Solin, Samuel A. Wickline, Kirk Wallace and Michael Hughes in 2007 and is headquartered in Chicago, IL. | Commercial Services |
Trasir Therapeutics, Inc.
Trasir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Altamira Therapeutics Ltd., Trasir Therapeutics, Inc. develops specialty pharmaceutical products. The company is based in Tampa, FL. The company was founded by Samuel A. Wickline. Trasir Therapeutics was acquired by Altamira Therapeutics Ltd. on June 03, 2021 for $4.32 million. | Health Technology |
- Bourse
- Insiders
- Samuel Wickline
- Expérience
